Skip to main content

Table 1 Baseline characteristics of the patients by treatment groups

From: Early effects of LT3 + LT4 combination therapy on quality of life in hypothyroid patients: a randomized, double-blind, parallel-group comparison trial

 

LT4 + Placebo

(N = 80)

LT4 + LT3

(N = 71)

Age, year

43.08 ± 11.36

42.24 ± 10.17

Gender, female

74 (92.5%)

70 (98.6%)

Weight, kg

72.10 ± 14.0

75.85 ± 12.8

SBP, mmHg

114.4 ± 14.4

114.8 ± 13.8

DBP, mmHg

71.75 ± 10.0

75.26 ± 7.8

TSH, mU/L

2(1.4–2.9)

2.4(1.4–3.3)

Physical activity,

Met-min/week

132.0(33.0–240.0)

89.0(33.5–175.5)

  1. Values are mean ± SD for normally distributed, median (Q1-Q3) for skewed continuous variables, and n (%) for categorical variables were reported
  2. SBP systolic blood pressure, DBP diastolic blood pressure, TSH thyroid-stimulating hormone